- Research
- Scientific Innovation
- Centers of Distinction
- Current Studies
- Researchers
- Publications
- Research News and Stories
- Brainerd Lakes Clinic
- International Cardiac Outreach, Research and Education (ICORE)
- Running with a mission
- Safer CT Scans
- Sickle Cell Trait and Sudden Death in Young Athletes
- Stem Cell Promise for Angina
- Sudden death in triathlons
- TRANSLATE-ACS Team Recognized
- MHIF Researchers Awarded $2 Million Grant
- Education
- Community Outreach
- News and Events
- About Us
- Donate Now
Learn more about what is involved by downloading our Study Participant Frequently Asked Questions (FAQ) or by contacting the research coordinator.
Download FAQ (PDF 53 KB)
SuperNOVA
SuperNOVA
Title: SuperNOVA: Stenting of the Superficial Femoral and Proximal Popliteal Arteries with the Boston Scientific INNOVA™ Self-Expanding Bare Metal Stent System
Study Sponsor: Boston Scientific
Principal Investigator: Andrew Cragg, MD
Study Synopsis: To determine whether the Innova™ Nitinol Stent System shows acceptable performance in long-term (12 months) safety rates and vessel patency when treating femoraopopliteal lesions.
Study Status: Open for enrollment
How do I qualify? Primary inclusion requires patients, when walking, to have considerable pain in their leg or calf that goes away when activity stops. The patient must also have a narrowing (stenosis) that meets study criteria.
Who do I contact for more information? Jo Anne Goldman, RT, RCIS, CCRC, or call research at 612.863.3980.
